Parkinsonism, premature menopause, and mitochondrial DNA polymerase γ mutations: clinical and molecular genetic study

Petri Luoma(Helsinki University Hospital), Atle Melberg(Uppsala University Hospital), Juha O. Rinne, Jyrki Kaukonen(University of Helsinki), Nina N. Nupponen(Helsinki University Hospital), R. M. Chalmers(National Hospital for Neurology and Neurosurgery), Anders Oldfors(Sahlgrenska University Hospital), I. Rautakorpi(Lapland Central Hospital), Leena Peltonen(University of Helsinki), Kari Majamaa(University of Oulu), Hannu Somer(Helsinki University Hospital), Anu Suomalainen(Helsinki University Hospital)
The Lancet
September 1, 2004
10.1016/s0140-6736(04)16983-3
Cited by 542

Abstract

Related Papers

Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Ranjita Betarbet, Todd Sherer, Gillian M. MacKenzie et al.|Nature Neuroscience|2000|3.7k
Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria
Johannes N. Spelbrink, Fang-Yuan Li, Valeria Tiranti et al.|Nature Genetics|2001|881
Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions
Gert Van Goethem, Bart Dermaut, A. Löfgren et al.|Nature Genetics|2001|836
An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region
Massimo Zeviani, Serenella Servidei, Cinzia Gellera et al.|Nature|1989|637
The harlequin mouse mutation downregulates apoptosis-inducing factor
Jeffrey A. Klein, Chantal M. Longo-Guess, Marlies P. Rossmann et al.|Nature|2002|608